Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
AEHR Manufacturing reported an intended sale of 7,000 common shares on a Form 144. The filing lists the shares as to be sold on 04/13/2026 (option granted 05/10/2021) and shows a prior sale of 3,500 shares on 04/10/2026 for $245,157.90 by Fariba Danesh. Broker listed: Fidelity Brokerage Services LLC.
Aehr Test Systems executive Vernon Rogers reported an open-market sale of 10,888 shares of Common Stock at $70.00 per share. After this transaction, he directly holds 167,540 shares. The reported holdings include shares that are subject to unvested restricted stock units.
AEHR Test Systems Chief Operating Officer Adil Engineer exercised stock options and sold shares in the company. He exercised options to acquire 10,582 shares of common stock at an exercise price of $9.45 per share, then sold 13,085 shares in open-market transactions at prices around the high‑$68 range. After these transactions, he directly holds 45,169 shares of AEHR common stock, and this amount includes shares underlying unvested restricted stock units.
AEHR Test Systems CTO Donald P. Richmond II reported an open-market sale of 15,751 shares of Common Stock on April 9, 2026 at an average price of $68.6849 per share. After this transaction, he directly holds 199,245 shares, which the footnote states includes shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS director Laura Oliphant reported an open-market sale of common stock by a trust associated with her. The trust sold 3,000 shares of AEHR common stock at a price of $68.3575 per share on April 9, 2026. After this transaction, the trust continued to hold 4,665 shares indirectly. Separately, Oliphant also reported direct ownership of 18,432 shares of common stock, some of which are subject to unvested restricted stock units.
Aehr Test Systems director Rhea J. Posedel, through a trust, sold 30,000 shares of common stock in an open-market transaction at $70.00 per share on April 9, 2026. After this sale, the trust still holds 426,979 shares indirectly, and Posedel also holds 71,163 shares directly. The indirect holdings include shares subject to unvested restricted stock units, indicating a continuing equity stake tied to ongoing service or vesting conditions.
Aehr Test Systems director Geoffrey Scott Gates reported indirect open-market sales of AEHR common stock made by his spouse. On April 9, 2026, the spouse sold a total of 35,000 shares in three transactions at prices between $67.75 and $68.00 per share.
After these sales, the filing shows the spouse holding 105,000 indirect shares, while an additional 60,686 shares are held indirectly by a trust and 52,864 shares are held directly by Gates. A footnote states the reported amounts include shares subject to unvested restricted stock units.
AEHR submitted a Form 144 notice reporting a proposed sale of Common Stock by an affiliate and disclosing a recent open-market sale. The filing lists a reported sale of 3,000 shares on 02/09/2026 for $82,715.25. The notice also lists multiple restricted stock vesting events (examples: 498 shares on 04/18/2024; 217 shares on 04/27/2024) and identifies Fidelity Brokerage Services LLC as the broker on the cover.